Foundation News

Lymphoma Research Foundation Elects Kristi Hendriks to Esteemed Board of Directors 

The Lymphoma Research Foundation – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services – today announced the election of Kristi Hendriks of Boston, MA to its Board of Directors.  

Lymphoma Research Foundation Elects New Scientific Advisory Board Members

Lymphoma Research Foundation Elects New Scientific Advisory Board Members Foundation welcomes four world-leading lymphoma experts to contribute to the global impact of the Foundation and guide the Foundation’s research portfolio The Lymphoma Research Foundation is proud to welcome four new…

Donor Spotlight: Leigh Olson

Major donor, Leigh Olson’s experience with the Lymphoma Research Foundation started in a doctor’s waiting room.

Tackling Obstacles On and Off the Field

In many ways, Timmy Ward is a typical college senior, majoring in sociology and playing football for the Rutgers Scarlet Knights – a Big Ten powerhouse. However, what most people don’t know is what he has had to overcome to get here.

Read the Latest Issue of Pulse: Spring 2024

Dear Friends of LRF, At the Lymphoma Research Foundation, our sights have always beenfixed to the horizon, looking ahead toward our vision of a world withoutlymphoma. Our focus on the future is why we have funded over $80Min lymphoma and…

Celebrating the Original ‘Chemo Diva’

Celebrating the Original ‘Chemo Diva’ Upon receiving a lymphoma diagnosis, it’s not uncommon to search for others like you who are going through a similar experience. That sense of community and support, of seeing your own story reflected to you,…

Morton Coleman, MD Innovation Fund

Morton Coleman, MD Innovation Fund Dr. Morton Coleman is a world-renowned and highly respected medical oncologist with nearly 60 years of experience in the field, specializing in the treatment of patients with lymphoma, multiple myeloma, and leukemia. In 2023, the…